Markets & Stocks
OCT Secures MHRA Approval For Clinical Trials, Cantourage Posts First Profits, & More From DanCann Pharma
Oxford Cannabinoid Technologies [stock_market_widget type=”chart” template=”basic” color=”#5679FF” assets=”OCTP.L” range=”1mo” interval=”1d” axes=”true” cursor=”true” range_selector=”true” display_currency_symbol=”true” api=”yf”] The London Stock
Ben Stevens
May 18, 2023
